A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
10/2002
10/24/2002	CA2490819A1 Compounds useful as anti-inflammatory agents
10/24/2002	CA2447008A1 Controlled delivery of tetracycline compounds and tetracycline derivatives
10/24/2002	CA2444840A1 Akt and regulation of ra synovial fibroblast apoptosis
10/24/2002	CA2444761A1 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations
10/24/2002	CA2444632A1 Vascular endothelial growth factor 2
10/24/2002	CA2444548A1 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
10/24/2002	CA2444465A1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and method
10/24/2002	CA2444247A1 Inhibitors of integrin .alpha.v.beta.6
10/24/2002	CA2444164A1 Pufa polyketide synthase systems and uses thereof
10/24/2002	CA2443995A1 Endothelial cell expression patterns
10/24/2002	CA2443897A1 Transporters and ion channels
10/24/2002	CA2443777A1 Therapeutic and diagnostic uses of antibody specificity profiles
10/24/2002	CA2443733A1 Peptide antiangiogenic drugs
10/24/2002	CA2443709A1 Novel cyclo azaphospha hydrocarbons
10/24/2002	CA2443697A1 1,4-disubstituted benzo-fused compounds
10/24/2002	CA2443487A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/24/2002	CA2443408A1 Kinases and phosphatases
10/24/2002	CA2443244A1 Enzymes
10/24/2002	CA2443234A1 Isoxaxole derivatives as inhibitors of src and other protein kinases
10/24/2002	CA2442943A1 Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers
10/24/2002	CA2433949A1 Compositions and methods for treating an arthritic condition
10/24/2002	CA2431553A1 Cxcr3 antagonists
10/23/2002	EP1251177A2 Cytokine-, stress-, and oncoprotein-activited human protein kinase kinases
10/23/2002	EP1250849A1 Morinda citrifolia (Noni) enhanced animal food product
10/23/2002	EP1250422A2 Myeloid colony stimulating factor and uses thereof
10/23/2002	EP1250358A1 Therapeutic peptides
10/23/2002	EP1250325A1 Phenanthridine-n-oxides
10/23/2002	EP1250317A2 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments
10/23/2002	EP1250313A1 Monohydrate of cis-lithium-cyano-4- 3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexanecarboxylate
10/23/2002	EP1250155A1 Angiogenesis and vascular permeability modulators and inhibitors
10/23/2002	EP1250142A1 Multivalent electron active compositions and methods of making and using same
10/23/2002	EP1250137A2 Jak/stat pathway inhibitors and the uses thereof
10/23/2002	EP1250055A1 Immune modulation with death receptor-induced apoptosis
10/23/2002	EP0925303B1 Phosphinic acid amides as matrix metalloprotease inhibitors
10/23/2002	EP0923561B1 Heterocyclic metalloprotease inhibitors
10/23/2002	EP0869947B1 Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
10/23/2002	CN1376156A Benzodiazepin derivatives, the production and use thereof
10/23/2002	CN1376153A Amide compounds
10/23/2002	CN1376146A Solid-state form of celecoxil having enhanced bioavailability
10/23/2002	CN1376144A Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
10/23/2002	CN1376067A Conditioned cell culture medium compositions and method of use
10/23/2002	CN1375328A Chinese medicine for treating cervical spondylopathy
10/23/2002	CN1375327A Plaster for treating hyperosteogeny
10/23/2002	CN1375326A Recipe of Chinese medicine for treating diseases caused by wind, cold and wetness
10/23/2002	CN1375324A Capsule for treating arthralgia of extremities and its prepn. process
10/23/2002	CN1375321A Plaster for treating hyperosteogeny, protrusion of interverterbral disc, arthritis and periarthritis of shoulder joint and its prepn.
10/23/2002	CN1375320A Chinese medicine for treating hyperosteogeny and its prepn.
10/23/2002	CN1375319A Chinese medicine for treating lumb limbs, sore waist and aching legs and its prepn.
10/23/2002	CN1375311A Composite Chinese medicine for treating rheumatic Bi syndrome
10/23/2002	CN1375310A Bone invigorating pills
10/23/2002	CN1375308A Chinese proprietary for treating protrusion of lumber interverterbral disc and its prepn.
10/23/2002	CN1093125C Sulfamide-metalloprotease inhibitors
10/23/2002	CN1092982C Medicine for treating hyperosteogeny
10/23/2002	CN1092962C Analgesic for osteonosus and osteoarthropthy
10/22/2002	US6469174 Substituted pyrrolobenzimidazoles for treating inflammatory diseases
10/22/2002	US6469162 Compounds with chelation affinity and selectivity for first transition series elements: use in medical therapy and diagnosis
10/22/2002	US6469054 Aryl sulphonamides and analogues
10/22/2002	US6469047 Tyrosine derivatives
10/22/2002	US6469045 Thalidomide and various related compounds such as thalidomide precursors, analogs, metabolites and hydrolysis products; oral administration
10/22/2002	US6469043 Antiangiogenic agent with antitumor, antimetastatic properties which shows high safety
10/22/2002	US6469036 Peptidyl heterocyclic ketones useful as tryptase inhibitors
10/22/2002	US6469025 For the prophylaxis or treatment of a disease or disorder in a mammal in which the extravasation of leukocytes plays a role; inhibiting the binding of alpha 4 integrins to their ligands
10/22/2002	US6469024 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
10/22/2002	US6469018 Compounds
10/22/2002	US6469004 Benzoheterocycles and their uses as MEK inhibitors
10/22/2002	US6468978 Conjugate comprising 1 to 4 moieties covalently bound to polypeptide comprising hedgehog n-terminal domain, each being polypeptide containing 10 to 30 hydrophobic amino acids or positively charged amino acids forming transmembrane helices
10/22/2002	US6468977 Compounds useful in treatment treatment of disorder and/or disease caused by activity of enzymes such as human rhinovirus 3c protease, transglutaminase and cathepsins
10/22/2002	US6468974 Oligopeptides that provide desirable in vitro and in vivo growth hormone releasing activity and have at least one other desirable biological activity such as increased retention time
10/22/2002	US6468960 Therapeutic compositions and methods for enhancing angiogenesis
10/22/2002	US6468756 Methods of identifying compounds that bind to SNORF25 receptors
10/22/2002	US6468536 Proteins extracted with perchloric acid from animal organs for preparation of medicaments active against autoimmune diseases, such as atherosclerosis, arthritis, multiple sclerosis, and diabetes; proteins uk 101 and uk 114; sequence
10/17/2002	WO2002081728A2 Quinoline inhibitors of hyak1 and hyak3 kinases
10/17/2002	WO2002081668A2 Desaturase genes and uses thereof
10/17/2002	WO2002081627A2 Methods of screening and using inhibitors of angiogenesis
10/17/2002	WO2002081522A1 Anti-osteopontin antibody and use thereof
10/17/2002	WO2002081521A2 Osteoprotegerin in milk
10/17/2002	WO2002081499A2 Somatostatin agonists
10/17/2002	WO2002081475A1 Jun kinase inhibitors
10/17/2002	WO2002081467A1 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
10/17/2002	WO2002081463A1 Antagonists of mcp-1 function and methods of use thereof
10/17/2002	WO2002081461A1 Piperazine derivatives as tachykinin antagonists
10/17/2002	WO2002081449A1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
10/17/2002	WO2002081420A1 Cyclooctanone derivative and cyclodecanone derivative, and use thereof
10/17/2002	WO2002081415A2 Method for inhibiting metap2
10/17/2002	WO2002081007A2 Methods of isolating blood components using a centrifuge and uses thereof
10/17/2002	WO2002080987A1 Anti-cd19 immunotoxins
10/17/2002	WO2002080973A1 Composition for use in therapy of hard tissue of mammal and method of therapy thereof
10/17/2002	WO2002080969A1 Remedies for infant chronic arthritis-relating diseases
10/17/2002	WO2002080955A1 Stimulation of osteogenesis using rank ligand fusion proteins
10/17/2002	WO2002080941A1 Compositions for preparing external carbon dioxide agents
10/17/2002	WO2002080933A1 A drug for use in bone grafting
10/17/2002	WO2002080926A1 Pyrazolopyrimidines as therapeutic agents
10/17/2002	WO2002080914A2 Use of substituted imidazo[1,2-a]-pyridine compounds as medicaments
10/17/2002	WO2002080888A2 Estrogen receptor-related receptor alpha (err) agonist for inducing cartilage formation
10/17/2002	WO2002080887A2 Timed pulse release composition
10/17/2002	WO2002080682A1 Improved anti-inflammatory herbal composition and method of use
10/17/2002	WO2002062301A3 Method and composition for rejuvinating cells, tissues, organs, hair and nails
10/17/2002	WO2002059114A9 Lfa-1 antagonist compounds
10/17/2002	WO2002056897A3 Pharmaceutical for stimulating the regeneration of tissues
10/17/2002	WO2002054851A3 Inhibition of pathological angiogenesis in vivo

1 ... 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 ... 820